Press Release

Emergency Contraceptive Pills Market to grow with a CAGR of 4.43%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Emergency Contraceptive Pills Market.

 

According to TechSci Research report, “Global Emergency Contraceptive Pills Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Emergency Contraceptive Pills Market has valued at USD 545.60 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.43% through 2028.  This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

Innovations in product development can drive the demand for Emergency Contraceptive Pills (ECPs) in the Global Emergency Contraceptive Pills Market. Ongoing research and development efforts can lead to the creation of more effective and well-tolerated ECP formulations. Innovations in formulation can result in pills that are easier to take, have reduced side effects, and offer higher efficacy. Innovations may extend the window of effectiveness for ECPs, allowing individuals more time to use them after unprotected sex. This extended timeframe can make ECPs even more reliable and accessible. Efforts to reduce side effects associated with ECPs, such as nausea or breast tenderness, can lead to greater user satisfaction and adherence, driving demand for these products. Innovations in product development may result in alternative delivery methods for emergency contraception, such as transdermal patches, vaginal rings, or intramuscular injections. These methods can offer convenience and potentially improve efficacy. Innovations in regulatory approval may lead to more ECP products being available over the counter without a prescription. This can increase access and demand among consumers. ECP manufacturers may innovate by offering comprehensive contraceptive solutions that include not only ECPs but also regular contraception methods. This approach can promote consistent contraceptive use. Innovations in packaging can make ECPs more user-friendly and convenient, which may encourage individuals to keep them on hand for emergencies.

Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions.

In November 2022, Major global pharmaceutical company Lupin Limited (Lupin) announced that its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg, to market a generic version of Slynd Tablets, 4 mg, of Exeltis USA Inc., has received provisional approval from the United States Food and Drug Administration (FDA). An international pharmaceutical firm with a focus on innovation, Lupin is based in Mumbai, India. The company creates and promotes a wide variety of branded and generic formulations, biotechnology goods, and APIs in more than 100 markets in the Americas, Europe, the Middle East, India, and South Africa.

 

Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on "Emergency Contraceptive Pills Market.”

 

Cultural and religious beliefs can present challenges in the Global Emergency Contraceptive Pills (ECPs) Market. These challenges can influence individuals' attitudes toward emergency contraception and affect the availability and acceptance of these pills in various regions. Some religious and cultural belief’s view contraception, including emergency contraception, as morally or ethically unacceptable. This can lead to resistance against the use of ECPs among individuals who adhere to such beliefs. Cultural and societal norms in certain regions may stigmatize discussions about contraception, especially outside of marital relationships. This stigma can deter individuals from seeking or using ECPs due to concerns about judgment or social pressure. Cultural and religious influences can contribute to limited awareness or misinformation about emergency contraception. Individuals may not be fully informed about the availability and proper use of ECPs. In some countries or regions with strong religious influences, there may be legal or regulatory restrictions on the sale and distribution of ECPs. These restrictions can limit access to emergency contraception. The beliefs and attitudes of healthcare providers, who may be influenced by cultural or religious values, can impact the quality of information and services related to ECPs. Providers who have moral objections may be less likely to offer ECPs or provide comprehensive information.

Global Emergency Contraceptive Pills Market segmentation is based on Type, Distribution Channel, and Region.

Based on Type, Global Emergency Contraceptive Pills Market is segmented into Combination Pills, Progesterone Pills, and Others. Progestin-only pills, often referred to as "progesterone pills" or mini-pills, are a type of oral contraceptive pill that contains a synthetic progestin hormone (not natural progesterone) but no estrogen. These pills are used for contraception and are sometimes prescribed to women who may not tolerate or should not take birth control pills containing estrogen. Progestin-only pills contain a synthetic progestin hormone as their active ingredient. They do not contain estrogen, which distinguishes them from combination birth control pills that contain both estrogen and progestin. Progestin-only pills primarily work by thickening cervical mucus, making it more difficult for sperm to reach and fertilize an egg. They also make the uterine lining less receptive to implantation, further reducing the chances of pregnancy. In some cases, they may suppress ovulation, but this is less consistent compared to combination birth control pills. Progestin-only pills are effective at preventing pregnancy when taken correctly and consistently. However, they require precise timing, with a strict daily regimen. Missing a pill or taking it at significantly different times can decrease their effectiveness.

Based on Region, North America dominated the Global Emergency Contraceptive Pills Market. There is a strong tradition of women's rights and reproductive health advocacy in North America. This has led to efforts to improve access to contraception, including emergency contraception. North America is home to many major pharmaceutical companies that manufacture and distribute emergency contraceptive pills. The presence of these companies in the region contributes to market dominance. Cultural attitudes in North America, while diverse, generally tend to be more accepting of contraception and family planning, which can lead to higher usage rates. The region also invests significantly in research and development of pharmaceutical products, leading to the development of newer and more effective emergency contraceptive options.

Asia-pacific region to fastest growth in the Global Emergency Contraceptive Pills Market. The Asia-Pacific region is home to a significant portion of the world's population, with several densely populated countries. The sheer size of the population can contribute to a higher demand for emergency contraceptive pills. Rapid urbanization and changing demographics in many Asian countries have led to shifts in lifestyle and sexual behavior, which can increase the likelihood of unprotected sex and the need for emergency contraception. Public health campaigns and efforts to raise awareness about sexual and reproductive health have been expanding in the Asia-Pacific region. Increased awareness can lead to greater knowledge about emergency contraception and its availability. Improved access to healthcare services, including family planning and contraception, in some parts of the region can make emergency contraceptive pills more accessible to a larger population. Attitudes toward contraception and family planning can vary widely across the region. In some countries, cultural and social norms may become more accepting of emergency contraception, leading to increased usage.

 

Some of the major companies operating in the Global Emergency Contraceptive Pills Market include:

  • Afaxys Pharma LLC
  • Bayer AG
  • Combe Inc.
  • Foundation Consumer Healthcare LLC
  • Gedeon Richter Plc
  • HLL Lifecare Ltd.
  • Knoll Healthcare Pvt. Ltd.
  • Laboratoire HRA Pharma SAS
  • Lupin Ltd.
  • Mankind Pharma Ltd.

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

“Certain areas, particularly in North America, are projected to exert significant demand for contraceptive pills. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Emergency Contraceptive Pills Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Emergency Contraceptive Pills Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028  Segmented by Type (Combination Pills, Progesterone Pills, and Others), by Distribution Channel (Retail Stores, Online Stores, and Others), by region, and Competition evaluated the future growth potential of Global Emergency Contraceptive Pills Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Emergency Contraceptive Pills Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News